Outpatient treatment of neutropenic fever with oval antibiotics and granulocyte colony-stimulating factor

Oncology

Volumn 57, Issue 2, 1999, Pages 127-130

  Papadimitris, Constantinos ^a   Dimopoulos, Meletios A ^a,b   Kostis, Evangelos ^a   Papadimitriou, Christos ^a   Anagnostopoulos, Athanassios ^a   Alexopoulos, George ^a   Papamichael, Christos ^a   Gika, Dimitra ^a   Mitsibounas, Dimitrios ^a   Stamatelopoulos, Stamatios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

Antibiotics, oral; Neutropenic fever

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; DOCETAXEL; GRANULOCYTE COLONY STIMULATING FACTOR; OFLOXACIN; PACLITAXEL;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; COST CONTROL; FEMALE; HUMAN; KIDNEY DISEASE; LYMPHOMA; MALE; NEUTROPENIA; ORAL DRUG ADMINISTRATION; OUTPATIENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SOLID TUMOR; SUBCUTANEOUS DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; AGED; AMBULATORY CARE; AMOXICILLIN; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; DRUG THERAPY, COMBINATION; FEMALE; FEVER; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; OFLOXACIN; PENICILLINS; TREATMENT OUTCOME;

EID: 0032857512     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012019     Document Type: Article

References (13)

1. Gardembas-Pain M, Desablens B, Sensebe L, et al: Home treatment of febrile neutropenia: An empirical oral antibiotic regimen. Ann Oncol 1991;2:485-487.
2. Malik IA, Abbas Z, Karim M: Randomized comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients. Lancet 1992;339:1092-1096.
3. Rubinstein EB, Rolston K, Benjamin RS, et al: Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer 1993;71:3640-3646.
4. Malik IA, Khan WA, Karim M, et al: Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: Results of a prospective randomized trial. Am J Med 1995; 98:224-231.
5. Escalante C, Rubenstein E, Rolston K: Outpatient antibiotics treatment in low-risk febrile neutropenic cancer patients. Support Care Cancer 1996;4:358-363.
6. Talcott JA, Finberg R, Mayer RJ, et al: The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Arch Intern Med 1988;148:2561-2568.
7. Talcott JA, Whalen A, Clark J, et al: Home antibiotic therapy for low-risk cancer patients with fever and neutropenia. A pilot study of 30 patients based on a validated prediction rule. J Clin Oncol 1994;12:107-114.
8. Viot M, Klastersky J: Prophylaxis and empiric therapy for streptococcal infections in febrile neutropenic patients. Eur J Cancer 1991;27: 819-820.
9. Maher DW, Lieschke GJ, Green M, et al: Filgrastim in patients with chemotherapy-induced febrile neutropenia. Ann Intern Med 1994;121:492-501.
10. Mayordomo JI, Rivera F, Diaz-Puente MT, et al: Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors. J Natl Cancer Inst 1995;87:803-808.
11. Ravaud A, Chevreau C, Cany L, et al: Granulocyte-macrophage colony stimulating factor in patients with neutropenic fever is potent after low-risk not after high-risk neutropenic chemotherapy regimens: Results of a randomized phase III trial. J Clin Oncol 1998;16:2930-2936.
12. Anaissie EJ, Vartivarian S, Bodey GP, et al: Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor in cancer patients with fever and neutropenia. Am J Med 1996;100:17-23.
13. Villenga E, Vyl-deGroot CA, De Wit R, et al: Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia. J Clin Oncol 1996;14:619-627.